Metraipolis › archive › dc_196efea42ae0

A Comparative Study of Oral Tofacitinib and Oral Methotrexate in the Treatment of Patients With Moderate to Severe Chronic Plaque Psoriasis — Europe PMC PMID:41822605

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41822605
DOI: 10.7759/cureus.103264
License (as archived): solo-consultazione
Archived: 2026-11-06T00:47:08.075Z
SHA-256 of the archived text: f5ee36947c562893ed5573a8d35aebe0ad8926255ad8c8e63f00d29cfc0434e2
Stable URL of this page: https://metraipolis.com/documento/dc_196efea42ae0

How to cite

A Comparative Study of Oral Tofacitinib and Oral Methotrexate in the Treatment of Patients With Moderate to Severe Chronic Plaque Psoriasis — Europe PMC PMID:41822605 — Europe PMC (en), https://europepmc.org/article/MED/41822605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_196efea42ae0 (Metraipolis archive dc_196efea42ae0, sha256 f5ee36947c562893ed5573a8d35aebe0ad8926255ad8c8e63f00d29cfc0434e2)

BibTeX

@misc{dc196efea42ae0,
  title = {A Comparative Study of Oral Tofacitinib and Oral Methotrexate in the Treatment of Patients With Moderate to Severe Chronic Plaque Psoriasis — Europe PMC PMID:41822605},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41822605},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_196efea42ae0; sha256 f5ee36947c562893ed5573a8d35aebe0ad8926255ad8c8e63f00d29cfc0434e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822605. Agents can read the archived copy with the MCP tool read_document.